Cytek Biosciences, Inc.

CTKB · XNAS

CIK 1831915fmd_0ZXJKYD5QSXNKCBCGJSF8MFJD8Manufacturing · Laboratory Analytical InstrumentsTemplate: Standard

Coverage: Jan 01, 2020 to Sep 30, 2026, 27 periods

Income Statement · Annual · Millions · USD
Line item	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	1	2	3	193	200	201
Cost of revenue	41	49	63	84	89	97
Gross profit	52	79	101	109	111	104
Research and development	14	24	35	44	39	36
Selling, general and administrative	24	46	68	93	92	108
Total operating expenses	38	70	103	137	132	145
Operating income	14	9	(2)	(28)	(21)	(40)
Interest expense	0	2	3	2	(5)	0
Interest and investment income	0	0	5	6	5	2
Other non-operating income (expense)	1	(3)	3	12	15	11
Income before taxes	14	6	1	(16)	(6)	(30)
Income tax expense	(5)	3	(1)	(4)	0	37
Net income from continuing operations	19	3	2	(12)	(6)	(67)
Net income	19	3	2	(12)	(6)	(67)
Net income to common shareholders	3	0	3	(12)	(6)	(67)